Literature DB >> 33391267

Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs.

Veerupaxagouda Patil1,2, Sankar Renu1,2, Ninoshkaly Feliciano-Ruiz1,2, Yi Han1,2, Anikethana Ramesh1,2, Jennifer Schrock1,2, Santosh Dhakal1,2, Harm HogenEsch3, Gourapura J Renukaradhya1,2.   

Abstract

We designed the killed swine influenza A virus (SwIAV) H1N2 antigen (KAg) with polyriboinosinic:polyribocytidylic acid [(Poly(I:C)] adsorbed corn-derived Nano-11 particle based nanovaccine called Nano-11-KAg+Poly(I:C), and evaluated its immune correlates in maternally derived antibody (MDA)-positive pigs against a heterologous H1N1 SwIAV infection. Immunologically, in tracheobronchial lymph nodes (TBLN) detected enhanced H1N2-specific cytotoxic T-lymphocytes (CTLs) in Nano-11-KAg+Poly(I:C) vaccinates, and in commercial vaccinates detected CTLs with mainly IL-17A+ and early effector phenotypes specific to both H1N2 and H1N1 SwAIV. In commercial vaccinates, activated H1N2- and H1N1-specific IFNγ+&TNFα+, IL-17A+ and central memory T-helper/Memory cells, and in Nano-11-KAg+Poly(I:C) vaccinates H1N2-specific central memory, IFNγ+ and IFNγ+&TNFα+, and H1N1-specific IL-17A+ T-helper/Memory cells were observed. Systemically, Nano-11-KAg+Poly(I:C) vaccine augmented H1N2-specific IFNγ+ CTLs and H1N1-specific IFNγ+ T-helper/Memory cells, and commercial vaccine boosted H1N2- specific early effector CTLs and H1N1-specific IFNγ+&TNFα+ CTLs, as well as H1N2- and H1N1-specific T-helper/Memory cells with central memory, IFNγ+&TNFα+, and IL-17A+ phenotypes. Remarkably, commercial vaccine induced an increase in H1N1-specific T-helper cells in TBLN and naive T-helper cells in both TBLN and peripheral blood mononuclear cells (PBMCs), while H1N1- and H1N2-specific only T-helper cells were augmented in Nano-11-KAg+Poly(I:C) vaccinates in both TBLN and PBMCs. Furthermore, the Nano-11-KAg+Poly(I:C) vaccine stimulated robust cross-reactive IgG and secretory IgA (SIgA) responses in lungs, while the commercial vaccine elicited high levels of serum and lung IgG and serum hemagglutination inhibition (HI) titers. In conclusion, despite vast genetic difference (77% in HA gene identity) between the vaccine H1N2 and H1N1 challenge viruses in Nano-11-KAg+Poly(I:C) vaccinates, compared to over 95% identity between H1N1 of commercial vaccine and challenge viruses, the virus load and macroscopic lesions in the lungs of both types of vaccinates were comparable, but the Nano-11-KAg+Poly(I:C) vaccine cleared the virus from the nasal passage better. These data suggested the important role played by Nano-11 and Poly(I:C) in the induction of polyfunctional, cross-protective cell-mediated immunity against SwIAV in MDA-positive pigs.
Copyright © 2020 Patil, Renu, Feliciano-Ruiz, Han, Ramesh, Schrock, Dhakal, HogenEsch and Renukaradhya.

Entities:  

Keywords:  Poly(I:C); corn-based nanovaccine; cross-protective cell meditated immunity; inactivated SwIAV; intranasal route; maternal antibody; maternally derived antibody positive pigs; polyfunctional T cells

Mesh:

Substances:

Year:  2020        PMID: 33391267      PMCID: PMC7772411          DOI: 10.3389/fimmu.2020.596964

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  52 in total

1.  One road to the TH17 pathway: how TH1 led to TH17 (and vice versa), and first came last.

Authors:  Casey T Weaver
Journal:  Nat Immunol       Date:  2020-08       Impact factor: 25.606

Review 2.  Swine influenza virus vaccines: to change or not to change-that's the question.

Authors:  Kristien Van Reeth; Wenjun Ma
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

3.  Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Induces Interleukin-17 Production via Activation of the IRAK1-PI3K-p38MAPK-C/EBPβ/CREB Pathways.

Authors:  Honglei Wang; Li Du; Fang Liu; Zeyu Wei; Li Gao; Wen-Hai Feng
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus.

Authors:  Mahesh Khatri; Varun Dwivedi; Steven Krakowka; Cordelia Manickam; Ahmed Ali; Leyi Wang; Zhuoming Qin; Gourapura J Renukaradhya; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

5.  Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study.

Authors:  Andrew C Hayward; Lili Wang; Nilu Goonetilleke; Ellen B Fragaszy; Alison Bermingham; Andrew Copas; Oliver Dukes; Elizabeth R C Millett; Irwin Nazareth; Jonathan S Nguyen-Van-Tam; John M Watson; Maria Zambon; Anne M Johnson; Andrew J McMichael
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

6.  Porcine reproductive and respiratory syndrome virus modifies innate immunity and alters disease outcome in pigs subsequently infected with porcine respiratory coronavirus: implications for respiratory viral co-infections.

Authors:  Kwonil Jung; Gourapura J Renukaradhya; Konstantin P Alekseev; Ying Fang; Yuxin Tang; Linda J Saif
Journal:  J Gen Virol       Date:  2009-08-05       Impact factor: 3.891

7.  Characterization of triple reassortant H1N1 influenza A viruses from swine in Ohio.

Authors:  H M Yassine; M Khatri; Y J Zhang; C W Lee; B A Byrum; J O'Quin; K A Smith; Y M Saif
Journal:  Vet Microbiol       Date:  2009-05-04       Impact factor: 3.293

8.  The T-Cell Response to Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV).

Authors:  Andrew R Kick; Amanda F Amaral; Lizette M Cortes; Jonathan E Fogle; Elisa Crisci; Glen W Almond; Tobias Käser
Journal:  Viruses       Date:  2019-08-29       Impact factor: 5.048

9.  Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses.

Authors:  Hadi M Yassine; Mohammad Q Al-Natour; Chang-Won Lee; Yehya M Saif
Journal:  Virol J       Date:  2007-11-28       Impact factor: 4.099

10.  In Vitro-Generated Tc17 Cells Present a Memory Phenotype and Serve As a Reservoir of Tc1 Cells In Vivo.

Authors:  Felipe Flores-Santibáñez; Bárbara Cuadra; Dominique Fernández; Mariana V Rosemblatt; Sarah Núñez; Pablo Cruz; Felipe Gálvez-Cancino; J César Cárdenas; Alvaro Lladser; Mario Rosemblatt; María Rosa Bono; Daniela Sauma
Journal:  Front Immunol       Date:  2018-02-08       Impact factor: 7.561

View more
  5 in total

1.  The gC1qR Binding Site Mutant PCV2 Is a Potential Vaccine Strain That Does Not Impair Memory CD4+ T-Cell Generation by Vaccines.

Authors:  Qian Du; Xuefeng Yang; Mengyu Ma; Qi Zhang; Changlei Zhu; Tengfei Shi; Mingrui He; Dewen Tong; Yong Huang
Journal:  J Virol       Date:  2022-09-19       Impact factor: 6.549

2.  Gut Microbiota of Obese Children Influences Inflammatory Mucosal Immune Pathways in the Respiratory Tract to Influenza Virus Infection: Optimization of an Ideal Duration of Microbial Colonization in a Gnotobiotic Pig Model.

Authors:  Sankar Renu; Loic Deblais; Veerupaxagouda Patil; Jennifer Schrock; Dipak Kathayat; Vishal Srivastava; Ninoshkaly Feliciano-Ruiz; Yi Han; Anikethana Ramesh; Yashavanth S Lakshmanappa; Shristi Ghimire; Santosh Dhakal; Gireesh Rajashekara; Gourapura J Renukaradhya
Journal:  Microbiol Spectr       Date:  2022-05-17

3.  Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens.

Authors:  Dexin Kong; Taoran Chen; Xiaolong Hu; Shaorong Lin; Yinze Gao; Chunmei Ju; Ming Liao; Huiying Fan
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

Review 4.  Alpha-D-glucan-based vaccine adjuvants: Current status and future perspectives.

Authors:  Veerupaxagouda Patil; Juan F Hernandez-Franco; Harm HogenEsch; Gourapura J Renukaradhya
Journal:  Front Immunol       Date:  2022-08-31       Impact factor: 8.786

5.  Mechanism of activation of porcine dendritic cells by an α-D-glucan nanoparticle adjuvant and a nanoparticle/poly(I:C) combination adjuvant.

Authors:  Juan F Hernandez-Franco; Shaojun Xie; Jyothi Thimmapuram; Darryl Ragland; Harm HogenEsch
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.